FibroBiologics, Inc. FBLG
NASDAQ · United States · Health Technology
$1.24+0.03 (+2.90%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-31 | -0.66 | -0.93 | +29.0% | $0 | — | +10.0%$0.72→$0.79 |
| Q1 2026 | 2026-04-30 | -1.33 | -1.26 | -5.6% | — | — | +11.5%$1.31→$1.46 |
| Q4 2025 | 2026-02-24 | -0.60 | -2.00 | +70.0% | — | — | +4.0%$5.06→$5.26 |
| Q3 2025 | 2025-10-31 | -2.60 | -2.30 | -13.0% | — | — | -0.5%$7.94→$7.90 |
| Q1 2025 | 2025-05-14 | -2.80 | -2.50 | -12.0% | — | — | — |
| Q4 2024 | 2025-03-31 | -1.80 | -1.40 | -28.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.